Business R&D investment set to grow by 5 per cent for next three years

Research by the European Union's Joint Research Centre (JRC) suggests that business investment in research and development (R&D) will increase by as much as five per cent per year for the next three years.

Increasing R&D investment is a key component of the Lisbon Strategy, and the blueprint for European innovation. The expert group report chaired by former Finnish Prime Minister Esko Aho explicitly refers to the Lisbon goal of increasing investment in research to three per cent of GDP. In 2005, only 1.91 per cent of GDP was spent on R&D in the EU.

Should this increase be mirrored across the board, then the figure could rise to almost 2.2 per cent of GDP spent on R&D by 2010 - short of Lisbon targets but still a huge improvement.

The European Commission's Seventh Framework Programme (FP7) will see huge increases in its budget compared to previous Framework Programmes. This money will go directly to research, but money also has to come from business. "If we are to reach our objective of investing 3 per cent of GDP in research and development, we need increased investment by the private sector," said European Commissioner for Science and Research, Janez Potocnik.

"For this reason the results of this survey are encouraging. We need to maintain and reinforce our efforts at European and national level to make Europe an attractive place for companies to carry out their research. The Commission will be coming forward with some more ideas in this area in autumn 2006," continued the Commissioner.

Perhaps unsurprisingly, companies prefer to invest in their own countries. The largest investors in R&D continue to be the largest economies - Germany, France and the UK. However, the skill of workforce and access to markets were found by the report to be significant factors. Meanwhile, cost of workforce was low. For EU companies, the US is the most attractive non-EU state to invest, followed by India and China.

Perhaps more importantly, "The incentives to increase R&D investment most often cited in the responses are: changes in market demand for new products and services, changes in technological opportunities, and changes in company turnover or profit. Changes in the availability and labour costs of researchers are the least often cited incentives for increasing R&D investment," reads the report.

This shows that companies are pragmatic, and respond to market and economic need. This also demonstrates the importance of developing lead markets for technological innovations, to encourage further research, as cited in the expert group report into innovation.

The survey questioned 449 firms in ten sectors: automobiles and parts; chemicals; electronic and electrical equipment; engineering and machinery; food producers and processors; health; IT hardware; pharmaceuticals and biotechnology; steel and other metals; and support services

For further information, please visit the European Commission's innovation portal and read the expert group report:
http://ec.europa.eu/invest-in-research/index_en.htm

Copyright ©European Communities, 2006
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg – http://cordis.europa.eu.int. Access to CORDIS is currently available free-of-charge.

Most Popular Now

AI Points the Way to Better Doctor-Patie…

A computer analysis of hundreds of thousands of secure email messages between doctors and patients found that most doctors use language that is too complex for their patients to understand...

Open Call DIGITAL-2021-DEPLOY-01-TWINS-H…

The development of digital twins in healthcare (DTH) has progressed substantially, profiting from advances in science and technology. In order to exploit their benefits in view of better prevention approaches...

Mayo Clinic Researchers Use AI, Biomarke…

Treatment options for rheumatoid arthritis have often relied on trial and error. Now Mayo Clinic researchers are exploring the use of artificial intelligence (AI) and pharmacogenomics to predict how patients...

Mjog by Livi Launches Remote Monitoring …

Mjog by Livi has launched a remote monitoring tool that will help GPs support and monitor people with depression through messages sent to their smartphones. The latest data from the Office...

Could EKGs Help Doctors use AI to Detect…

Pulmonary embolisms are dangerous, lung-clogging blot clots. In a pilot study, scientists at the Icahn School of Medicine at Mount Sinai showed for the first time that artificial intelligence (AI)...

Computer Model of Blood Enzyme

Membrane-associated proteins play a vital role in a variety of cellular processes, yet little is known about the membrane-association mechanism. Lipoprotein-associated phospholipase A2 (Lp-PLA2) is one such protein with an...

4.5 Million Euros in EU Funding for Saar…

This year, three computer scientists from Saarbrücken were awarded an "ERC Starting Grant" by the European Research Council. This award, endowed with 1.5 million euros each, is among the most...

2022 EU4Health Work Programme Adopted to…

Today the Commission has adopted the second EU4Health work programme. In 2022, the EU4Health will continue to invest in building stronger, more resilient health systems and pave the way for...

Five NHS Trusts in Surrey and Sussex to …

A consortium of NHS trusts that covers a population of circa 1.2 million will gain immediate access to important patient imaging, and will mobilise a regional workforce for patients, following...

Helping Cancer Patients Avoid Excessive …

A Case Western Reserve University-led team of scientists has used Artificial Intelligence (AI) to identify which patients with certain head and neck cancers would benefit from reducing the intensity of...

The Programme for the Union's Action in …

On 24 March 2021, Regulation (EU) 2021/522 of the European Parliament and of the Council1 was adopted as part of the Multiannual Financial Framework for the 2021-2027 period. That Regulation...

CliniSys Acquires HORIZON Lab Systems an…

CliniSys is announcing the recent acquisition of HORIZON Lab Systems and the combination with Sunquest Information Systems, as CliniSys. This acquisition and Sunquest combination creates one of the world’s...